Studies using rodents indicate that increases in oxidative stress could be responsible for developing DN; inhibition of the polyol pathway with aldose reductase inhibitors could reduce the effects of hyperglycemia on DN [36]. Here, AKR1B1 is linked to liver dysplastic nodule.